Literature DB >> 2289782

Plasma beta-endorphin during fasting in man.

G Komaki1, H Tamai, H Sumioki, T Mori, N Kobayashi, K Mori, S Mori, T Nakagawa.   

Abstract

To identify the effects of acute starvation on endogenous opioids in man, plasma beta-endorphin (beta-EP) was measured in 17 patients before, during and after fasting. Patients were assigned a posteriori into two groups: group A, comprised of 11 patients able to tolerate 5-7 days of fasting, and group B, comprised of 6 patients able to tolerate 10 days of fasting. Changes in plasma beta-EP, serum cortisol, circulating nutritional markers, and their relative levels were assessed on the 5th and 10th days of fasting, and on the 5th and 10th days of the refeeding period. Beta-EP had increased by the 5th day (group A: 4.74 +/- 0.42 to 6.91 +/- 0.65 pmol/l, p less than 0.01; group B: 3.60 +/- 0.48 to 5.14 +/- 0.22 pmol/l, p less than 0.05, and remained at 5.05 +/- 0.65 pmol/l on the 10th day (group B: 0.05 less than p less than 0.1) during fasting. Group B had lower levels of plasma beta-EP on the 5th day of fasting than group A (p less than 0.05). However, serum cortisol levels changed similarly in both groups. Plasma beta-EP showed no significant correlation with either the percentage of body weight lost or the body mass index (kg/m2) over this study period. These findings indicate that plasma beta-EP is elevated in the early phase of fasting, while not directly being associated with body weight changes. Plasma beta-EP is lower and less activated in subjects who are able to tolerate fasting for longer periods.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289782     DOI: 10.1159/000181525

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

Review 1.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

2.  Effects of fasting therapy on irritable bowel syndrome.

Authors:  Motoyori Kanazawa; Shin Fukudo
Journal:  Int J Behav Med       Date:  2006

3.  AMP-activated kinase and the endogenous endocannabinoid system might contribute to antinociceptive effects of prolonged moderate caloric restriction in mice.

Authors:  Tanya Sarah King-Himmelreich; Christine Verena Möser; Miriam Christina Wolters; Julia Schmetzer; Moritz Möller; Yannik Schreiber; Nerea Ferreirós; Gerd Geisslinger; Ellen Niederberger
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

Review 4.  The Effect of Fasting on Human Metabolism and Psychological Health.

Authors:  Yiren Wang; Ruilin Wu
Journal:  Dis Markers       Date:  2022-01-05       Impact factor: 3.434

Review 5.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

Review 6.  Environment, human reproduction, menopause, and andropause.

Authors:  A Vermeulen
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

7.  Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects.

Authors:  Françoise Wilhelmi de Toledo; Franziska Grundler; Audrey Bergouignan; Stefan Drinda; Andreas Michalsen
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.